Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

Kindle

Jean-Pierre Majoral,Anne-Marie Caminade with emphasis on humoral and cellular treatment modalities. Only recently, two monoclonal antibodies (mAbs), ipilimumab and nivolumab (BMS936558), have dramatically changed the outcome of melanoma treatments which were once almost nonexistent. In a dramatic analogy, these monoclonal antibodies seem

外貌

th the aim of educating clinicians on advances in cancer immunology and the most recent approaches in the immunotherapy of various tumors. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists.978-3-662-51384-2978-3-662-46410-6

燒瓶

Cancer Immunotherapy Confers a Global Benefit, addition, immunotherapy helps recover an injured or completely destroyed immune system after intensive cancer therapies as occurred in intensive chemotherapy schedules. A broad spectrum of immunotherapeutic medications has been developed to treat patients with cancers. Adoptive cell therapy, therap

榨取

粗語

Immunopathology and Immunotherapy of Myeloid Leukemia,overview of candidate antigens to target in AML is given, followed by the currently described passive and active immunotherapeutic strategies. Active immunotherapy (e.g., modified leukemic cells, peptide, DNA, or dendritic cell-based vaccinations) requires a patient with an intact immune system and

故意

罵人有污點(diǎn)

Tumor Immunotherapy of Esophageal and Gastric Cancers,eveloped. This chapter reviews the promising strategies that employ monoclonal antibodies, adoptive cell transfer, and vaccine-based immunotherapy for the treatment of esophageal and gastric cancers. To date, several cancer vaccine trials have been performed in patients with advanced esophageal and

maculated

Immunopathology of Hepatobiliary Tumors and Immunotherapy of Liver Cancers,nogenesis and progression has been unveiled. Cytokines and lymphokines such as interleukin-6 and lymphotoxin, together with immune cells such as tumor-associated macrophages, play an important role in this process. Disruption in normal immune regulatory mechanisms provides additional therapeutic tar

chuckle

Oscillate

Immunotherapy of Pancreatic Cancer,on, along with the development of early pancreatic tumors in mouse models have provided new opportunities for pancreatic cancer treatment and prevention. Immunotherapy for pancreatic cancer is a therapeutic approach that is designed to target pancreatic-cancer-associated antigens and regulatory sign